Literature DB >> 9672336

Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.

M Yoshihara1, K Sumii, K Haruma, K Kiyohira, N Hattori, Y Kitadai, K Komoto, S Tanaka, G Kajiyama.   

Abstract

OBJECTIVE: Gastric cancer (GC) and adenoma (GA) are reported to be related to atrophic gastritis, in which the serum pepsinogen (PG) I level and the PGI/PGII ratio (I/II ratio) are reduced. To verify that the finding of a low PG level increases the risk for GC and GA, we investigated the correlation between low PG levels and the prevalence of GC and GA in individuals.
METHODS: The 2,039 subjects (734 Japanese men, mean age 68.5 yr, and 1,305 women, mean age 66.7 yr), selected from among 10,996 local residents who underwent health check-ups based on reductions in their serum PG levels, underwent upper gastrointestinal endoscopy.
RESULTS: Gastrointestinal endoscopy detected 21 GCs and 15 GAs. The prevalence of GC was higher than that in the residents without low serum PG. The percentage of early stage of GC (90%) was significantly higher than that of GC detected in unscreened residents (56.9%). The prevalence of GC in men was closely and significantly correlated with the I/II ratio (r = 0.935, p = 0.0063), whereas there was less correlation with age (r = 0.842, p = 0.0734). The prevalence of GA was also closely and significantly correlated with the I/II ratio in men (r = 0.881, p = 0.0203), but not with age (r = 0.163, p = 0.7928). In women the prevalence of GC (r = 0.744, p = 0.090) and GA (r = 0.678, p = 0.1392) did not correlate as strongly with the I/II ratio, although the highest prevalence was seen in the group with the lowest I/II ratio.
CONCLUSION: Our study verified that a low I/II ratio signifies a high risk for GC and GA and that measuring serum PG levels can be used as a screening method for GC and GA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672336     DOI: 10.1111/j.1572-0241.1998.00335.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  37 in total

1.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

2.  Features of Gastric Neoplasm Detected during the Screening Examination.

Authors:  Min Jung Park; Dong Hee Kim; Seon Hee Lim; Jeong Yoon Yim; Young Sun Kim; Kyung Ran Cho; Chung Hyeon Kim; Hyun Chae Jung; In Sung Song; Sun Sin Kim; Dae Hyun Yoon; Chan Soo Shin; Sang-Heon Cho; Byung-Hee Oh; Dong Ho Lee
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

3.  Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test.

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2012-01-05       Impact factor: 4.849

4.  High expression of gastrin receptor protein in injured mucosa of Helicobacter pylori-positive gastritis.

Authors:  Akemi Takamura; Masanori Ito; Tomoyuki Boda; Yoko Matsumoto; Shinji Tanaka; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2012-10-05       Impact factor: 3.199

5.  Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study.

Authors:  Shinobu Imagawa; Masaharu Yoshihara; Masanori Ito; Shigeto Yoshida; Yoshihiro Wada; Masana Tatsugami; Akemi Takamura; Shinji Tanaka; Ken Haruma; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2007-11-13       Impact factor: 3.199

6.  Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.

Authors:  S Nakamura; T Matsumoto; Y Kobori; M Iida
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Possibility of non-invasive diagnosis of gastric mucosal precancerous changes.

Authors:  Victor D Pasechnikov; Sergey Z Chukov; Sergey M Kotelevets; Alexander N Mostovov; Varvara P Mernova; Maria B Polyakova
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

8.  Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

9.  Is there a difference in gastric emptying between myotonic dystrophy type 1 patients with and without gastrointestinal symptoms?

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2013-01-24       Impact factor: 4.849

10.  Benign gastric polyps: morphological and functional origin.

Authors:  Kurt Borch; John Skarsgård; Lennart Franzén; Sven Mårdh; Jens F Rehfeld
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.